Arimidex/Tamoxifen Neo Adjuvant Study in Premenopausal Patients With Breast Cancer Under Anti Hormonal Treatment
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Tamoxifen|DRUG: Anastrazole (Arimidex)|DRUG: Goserelin acetate (Zoladex)
Sponsor: AstraZeneca